Treprostinil - NDC Database


17 records found:

Sorted by NDC Code

Page of 1
0703-0666 Sep 30, 2019
Treprostinil 20 mg/20ml Intravenous; Subcutaneous Solution by Teva Parenteral Medicines, Inc.
0703-0676 Sep 30, 2019
Treprostinil 50 mg/20ml Intravenous; Subcutaneous Solution by Teva Parenteral Medicines, Inc.
0703-0686 Sep 30, 2019
Treprostinil 100 mg/20ml Intravenous; Subcutaneous Solution by Teva Parenteral Medicines, Inc.
0703-0696 Sep 30, 2019
Treprostinil 200 mg/20ml Intravenous; Subcutaneous Solution by Teva Parenteral Medicines, Inc.
0781-3420 Mar 25, 2019
Treprostinil 20 mg/20ml Intravenous; Subcutaneous Injection by Sandoz Inc
0781-3425 Mar 25, 2019
Treprostinil 50 mg/20ml Intravenous; Subcutaneous Injection by Sandoz Inc
0781-3427 Mar 25, 2019
Treprostinil 100 mg/20ml Intravenous; Subcutaneous Injection by Sandoz Inc
0781-3430 Mar 25, 2019
Treprostinil 200 mg/20ml Intravenous; Subcutaneous Injection by Sandoz Inc
42023-206 Sep 25, 2019
Treprostinil 1 mg/ml Intravenous; Subcutaneous Injection, Solution by Par Pharmaceutical, Inc.
42023-207 Sep 25, 2019
Treprostinil 2.5 mg/ml Intravenous; Subcutaneous Injection, Solution by Par Pharmaceutical, Inc.
42023-208 Sep 25, 2019
Treprostinil 5 mg/ml Intravenous; Subcutaneous Injection, Solution by Par Pharmaceutical, Inc.
42023-209 Sep 25, 2019
Treprostinil 10 mg/ml Intravenous; Subcutaneous Injection, Solution by Par Pharmaceutical, Inc.
66302-150 May 22, 2002
Sterile Diluent for Remodulin 1 ml/Ml Intravenous Injection, Solution by United Therapeutics Corporation
66302-300 Dec 20, 2013
Orenitram .125 mg/1 Oral Tablet, Extended Release by United Therapeutics Corp.
66302-302 Dec 20, 2013
Orenitram .25 mg/1 Oral Tablet, Extended Release by United Therapeutics Corp.
66302-310 Dec 20, 2013
Orenitram 1 mg/1 Oral Tablet, Extended Release by United Therapeutics Corp.
66302-325 Dec 20, 2013
Orenitram 2.5 mg/1 Oral Tablet, Extended Release by United Therapeutics Corp.

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 December 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA